- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nerve Growth Factors in Canada
Total 814 results
-
PfizerCompletedMelanomaUnited States, Australia, Canada, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Bristol-Myers SquibbCompletedMelanomaCanada, Australia, Germany, Italy, Poland, France, Denmark, Argentina, Chile, Spain, Norway, Israel, Sweden, Mexico, Greece, Finland
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
Nationwide Children's HospitalChildren's Hospital ColoradoRecruitingAdamantinomatous Craniopharyngioma | Recurrent Adamantinomatous CraniopharyngiomaUnited States, United Kingdom, Australia, Canada, Germany, Netherlands
-
National Cancer Institute (NCI)RecruitingMetastatic Pancreatic Neuroendocrine Tumor | Pancreatic Neoplasm | Stage III Pancreatic Neuroendocrine Tumor AJCC v8 | Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 | Unresectable Pancreatic Neuroendocrine TumorUnited States, Canada
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingStage III/IV MelanomaUnited States, Australia, Canada, Italy, Switzerland
-
Jennerex BiotherapeuticsCompletedMelanoma | Renal Cell Carcinoma | Lung Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
Camurus ABActive, not recruitingGastro-enteropancreatic Neuroendocrine TumorUnited States, Belgium, Spain, Netherlands, France, Germany, Israel, Italy, Canada, Australia, Romania, Hungary
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
MedImmune LLCCompletedNeuromyelitis Optica and Neuromyelitis Optica Spectrum DisordersUnited States, Czechia, Thailand, Germany, Korea, Republic of, Israel, New Zealand, Spain, Taiwan, Japan, Turkey, Hungary, Bulgaria, Mexico, Russian Federation, Colombia, Peru, Poland, Estonia, South Africa, Canada, Australia, Hong... and more
-
Nationwide Children's HospitalChildren's Hospital ColoradoRecruitingAdamantinous Craniopharyngioma | Recurrent Adamantinomatous CraniopharyngiomaUnited States, United Kingdom, Australia, Canada, Germany, Netherlands
-
BayerAmgenCompletedMelanomaUnited States, Canada, Germany, France, United Kingdom, Australia, Netherlands
-
Bristol-Myers SquibbMedarexCompletedMelanomaFrance, United States, Australia, Belgium, Germany, South Africa, Canada, Brazil, Czech Republic, Hungary
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory NeuroblastomaUnited States, Canada
-
AstraZenecaActive, not recruitingMelanomaFrance, Germany, Italy, Spain, Belgium, Canada, Poland, Korea, Republic of, United Kingdom, United States, Australia
-
Hoffmann-La RocheCompletedHigh Grade GliomaUnited Kingdom, Canada, Austria, Italy, Spain, Sweden, Belgium, Denmark, France, Australia, Czechia, Hungary, Netherlands, Poland
-
Hoffmann-La RocheRecruitingMelanomaBrazil, Czechia, Spain, Turkey, New Zealand, Canada, Australia, Poland, Slovakia, Greece
-
Apexigen America, Inc.TerminatedMelanoma | Cancer | Metastatic Melanoma | Melanoma (Skin) | Unresectable Melanoma | Cancer of SkinSpain, Poland
-
Bristol-Myers SquibbCompletedMelanomaGermany, Italy, Sweden, United Kingdom, Belgium, Netherlands, Spain, Finland, Austria, Ireland, Poland, Portugal, Russian Federation, Switzerland, Czechia, Greece, Hungary, Luxembourg, Norway, Romania
-
Hoffmann-La RocheCompletedMetastatic CancersSpain
-
Philogen S.p.A.RecruitingMelanoma Stage IIIB/CSpain, United States, Switzerland
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center; University of Colorado... and other collaboratorsCompleted
-
Denovo Biopharma LLCCompleted
-
PfizerCompletedGlioblastomaSouth Africa, Italy, Russian Federation, United States, Canada, Germany, Australia, Austria, Croatia, Czech Republic, France, India, Spain
-
Novartis PharmaceuticalsCompletedMedulloblastomaFrance, Spain, Germany, Italy, Netherlands, United Kingdom, Canada, Australia, Sweden, United States, Brazil, Switzerland, Russian Federation
-
BioVex LimitedAmgenCompletedMelanomaUnited States, United Kingdom, Canada, South Africa
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Poland, United Kingdom, United States, Spain, Belgium, Denmark, Germany, Norway, Switzerland, Argentina, Austria, Sweden, Czechia, Hungary, Netherlands, Mexico, Canada, Israel, South Africa
-
IDEAYA BiosciencesRecruitingUveal MelanomaUnited States, Australia, Canada, Netherlands, Italy, France, Germany, United Kingdom
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Spain, Germany, Mexico, Turkey, Canada, Austria, Netherlands, United Kingdom, Italy, Georgia, France, Brazil, Romania, Czechia, Argentina, Australia, Ireland, Chile, Hungary, South Africa, Belgium, Poland, Peru
-
European Organisation for Research and Treatment...NCIC Clinical Trials GroupCompletedBrain and Central Nervous System TumorsCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | Neurofibromatosis Type 1Canada, United States
-
Immunocore LtdCompletedUveal MelanomaSpain, United States, Germany, Canada, United Kingdom
-
Beth Israel Deaconess Medical CenterBiogenCompletedMultiple Sclerosis | Optic Neuritis | Transverse Myelitis | Acute Brainstem/Cerebellar SyndromeUnited States, Canada
-
University of California, San FranciscoGenentech, Inc.Active, not recruitingPediatric Recurrent/Refractory BRAFV600E-mutant GliomasUnited States, Canada
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States, Australia, Canada
-
Helsinn Healthcare SALabcorp Drug Development IncWithdrawnAdvanced Solid Tumor | CNS Tumor | Recurrent WHO Grade II GliomaUnited States, Canada, Germany
-
Synta Pharmaceuticals Corp.TerminatedMelanomaUnited States, Spain, Canada, Australia, Germany, Puerto Rico, Romania, United Kingdom
-
Hoffmann-La RocheCompletedGlioblastomaUnited Kingdom, Austria, Croatia, France, Italy, Spain, Turkey, Romania, Portugal, Canada, Greece, Sweden, Bulgaria, Estonia, Latvia
-
Hoffmann-La RocheCompletedGlioblastomaUnited States, United Kingdom, France, Italy, Spain, Germany, Canada, Switzerland
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more
-
Genta IncorporatedCompletedMelanomaUnited States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
-
Ocellaris Pharma, Inc.RecruitingSarcoma | Neoplasms | Renal Cell Carcinoma | Cervical Cancer | Cancer | Hepatocellular Carcinoma | Gastric Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Squamous... and other conditionsCanada
-
Hoffmann-La RocheCompletedRenal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant MelanomaCanada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
-
GlaxoSmithKlineCompletedCancerAustralia, Spain, United States, Germany, Poland, Italy, Canada, Ireland, Hungary, Russian Federation, Netherlands, France
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingMelanomaUnited States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Mexico, Norway, Romania, Spain, Sweden, Switzerland, United Kingdom